<DOC>
	<DOCNO>NCT01575652</DOCNO>
	<brief_summary>The objective study examine effect angiotensin convert enzyme inhibitor peritoneal membrane transport , peritoneal protein loss , proteinuria peritoneal dialysis patient .</brief_summary>
	<brief_title>Effects Aceis Peritoneal Protein Loss Solute Transport pd Patients</brief_title>
	<detailed_description>This prospective cohort study conduct Unit Nephrology Sisli Etfal Education Research Hospital , Istanbul , Turkey . Prior subject recruitment , study protocol review approved local ethic committee , accordance ethical principle human investigation , write informed consent obtain patient . Between june 2008 january 2009 , 54 age gender match continuous ambulatory peritoneal dialysis ( CAPD ) patient include study consecutively . Patients divide 2 group accord decision physician ; group 1 ( n=34 ) consist patient treated ACE-Is group 2 ( n=30 ) treat ACEs . The inclusion criterion chronic PD patient 18 85 year receive antihypertensive drug within prior 12 month . All patient standard CAPD program ( 2-2.5 L ; 4 exchanges/day ) . Icodextrin use . The exclusion criterion follow ; patient history antihypertensive treatment ACE-Is angiotensin-receptor blocker aldosterone antagonists prior 12 month study time ; intolerance ACE-Is ; CAPD-related peritonitis within 6 month prior study period ; history malignant hypertension hypertensive encephalopathy cerebrovascular accident within 6 month prior study ; chronic liver disease , recent acute illness and/or history overt chronic inflammatory disease . Demographic variable include etiology CKD , age , gender obtain patient ' clinic chart . All blood sample take 10 hour overnight fast . Serum urea , creatinine , albumin level analyze . Creatinine clearance [ ( CCr ) dialysate , urine , total ] , Kt/V ( dialysate , urine , total ) calculate weekly . Daily volume ( UF ) , 24-hour protein , albumin loss ( dialysate , urine ) record also . Parameters begin study end 6th month evaluate . During study , dialysis regime remain patient . In group , investigator analyze blood , 24-hour urine ( patient residual diuresis &gt; 100mL daily ) , peritoneal effluent fluid 4 hour ' 24 hour ' dwell time . Peritoneal effluent fluid 24 hour ' dwell time use determine total protein , albumin , 24 hour ' dwell time determine urea creatinine . The urea kinetic test closest time proximity PET use analysis . After subject rest supine position least 15 minute blood pressure measure standard mercury sphyngomanometer three time half cuff around right arm . Patients ' blood pressure measurement perform regular basis every month . The mean value calculate . All patient receive standard 35-cal/kg/day carbohydrate , 1-2 g/kg/day protein , salt restrict diet . Patients use essential amino acid peritoneal dialysis solution contain amino acid . Serum urea , creatinine , albumin level assess enzymatic colorimetric assay . Dialysate adequacy ( Kt/V urea : dialysis residual ) , peritoneal transport ( 4-hour D/PCr ) measure use standard procedure ( PD Adequest 1.4 , 1994 : Baxter Healthcare Corporation , Deerfield , IL , U.S.A. ) . Dialysate albumin loss measure Bromo Cresol Green ( BCG ) method . Dialysate total protein loss measure Biuret method . Urine protein concentration determine immunoturbidimetric method . Statistical analysis carry use SPSS 13.0 software package ( SPSS Inc , Chicago , IL , USA ) . Kolmogorov-Smirnov test use test normality data distribution . Data express arithmetic mean standard deviation . Chi-square test use compare categorical variable group . Independent sample T-test Mann-Whitney U test use respectively group normally abnormally distribute continuous variable . Paired t-test Wilcoxon signed-rank test use analyze change within group . Two-sided p value &lt; 0.05 consider statistically significant .</detailed_description>
	<mesh_term>Enzyme Inhibitors</mesh_term>
	<mesh_term>Angiotensin-Converting Enzyme Inhibitors</mesh_term>
	<criteria>chronic peritoneal dialysis First paragraph . 18 55 year antihypertensive drug usage prior 12 month usage antihypertensive prior 12 month intolerance acei CAPD related peritonitis prior 6 month study time history malignant hypertension hypertensive encephalopathy cerebrovascular accident within 6 month prior study chronic liver diseases recent acute illness and/or history overt chronic inflammatory disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>peritoneal dialysis</keyword>
	<keyword>protein loss</keyword>
</DOC>